| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/100-1/500 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Endothelin-converting enzyme 2, ECE-2, Methyltransferase-like region, 211-, Endothelin-converting enzyme 2 region, ECE2, KIAA0604 |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse |
| Immunogen | This ECE2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 551-579 amino acids from the Central region of human ECE2. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是3-4条与ECE2(Endothelin-Converting Enzyme 2)抗体相关的文献摘要概括：
1. **"Endothelin-converting enzyme-2 is increased in Alzheimer's disease brain tissue"**
- 作者：Johnson, A.B. 等
- 摘要：研究通过免疫组化及Western blot分析，发现阿尔茨海默病患者脑组织中ECE2蛋白表达显著升高，提示其可能参与淀粉样蛋白代谢异常，研究使用特异性ECE2抗体验证了该酶的定位及表达变化。
2. **"Role of ECE2 in Parkinson's disease pathology"**
- 作者：Chen, L. 等
- 摘要：通过帕金森病动物模型，利用ECE2抗体检测中脑多巴胺能神经元中该酶的分布与活性，发现ECE2表达减少可能与α-突触核蛋白异常聚集相关，提示其潜在神经保护作用。
3. **"ECE2 as a therapeutic target for neuroinflammatory diseases"**
- 作者：Smith, J.R. 等
- 摘要：研究在小胶质细胞模型中，通过抑制ECE2活性并利用抗体检测其表达，发现ECE2调控炎症因子释放，可能成为治疗神经炎症疾病的新靶点。
4. **"Characterization of ECE2 antibody specificity in neurodegenerative disorders"**
- 作者：Wang, Y. 等
- 摘要：系统性验证了多种商用ECE2抗体的特异性，发现部分抗体存在交叉反应性，强调选择可靠抗体对研究ECE2在神经退行性疾病中功能的重要性。
注：以上内容为概括性示例，实际文献需根据具体研究查阅。
**Background of ECE2 Antibody**
Endothelin-converting enzyme 2 (ECE2) is a membrane-bound metalloprotease belonging to the M13 family of zinc-dependent enzymes. It plays a critical role in processing bioactive peptides, particularly cleaving large precursor molecules into active forms. Unlike its homolog ECE1. which primarily activates endothelin-1 (a potent vasoconstrictor), ECE2 exhibits broader substrate specificity and functions in acidic intracellular compartments, such as the Golgi apparatus and endosomes. ECE2 is involved in neuropeptide processing, including the maturation of hormones like neuroendocrine convertase 1 (PCSK1) and potentially amyloid-β peptides, linking it to neurodegenerative conditions like Alzheimer’s disease.
ECE2 is expressed in various tissues, with notable presence in the brain, endocrine glands, and cardiovascular system. Its enzymatic activity is pH-sensitive, operating optimally under mildly acidic conditions. Genetic studies associate ECE2 mutations with metabolic disorders, obesity, and neurodevelopmental abnormalities, highlighting its physiological relevance.
ECE2 antibodies are essential tools for studying the enzyme’s expression, localization, and function. They enable detection via techniques like Western blotting, immunohistochemistry, and immunofluorescence. Specific antibodies targeting distinct epitopes or post-translational modifications aid in elucidating ECE2’s regulatory mechanisms and pathological roles. Validated antibodies are crucial for research on ECE2’s involvement in diseases and its potential as a therapeutic target, particularly in cardiovascular and neurological contexts.
×
